All In MedTech

Device Trial Radar · NCT04609020

Study to Evaluate Subject Satisfaction With Facial Appearance and Impact of Combined Facial Treatment

Prospective, Multi-site Study to Evaluate Subject Satisfaction With Facial Appearance Overall and the Aesthetic and Psychosocial Impact of Combined Facial Treatment

Last checked: Nov 20, 2026Latest source record: Jun 17, 2025 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registry

Status

Completed

Enrollment

64

Actual

Start

Feb 15, 2023

Primary completion

May 10, 2024

Study completion May 10, 2024

Sponsor

Lead sponsor
AllerganNot on our public-company list
Sponsor type
Industry
First posted
Oct 30, 2020

More device trials from this sponsor

Design

Study type
Interventional
Phase
Phase 4
Allocation
Not applicable (single group)
Model
Single group
Masking
None
Primary purpose
Treatment
FDA-regulated device
Yes
Who can join
All sexes, from 35 years, up to 65 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The primary objective of this study is to quantify the psychological, social, and emotional impact of comprehensive aesthetic treatment with a portfolio of the Sponsor's products by measuring the change in subject's satisfaction with facial appearance from baseline (before any treatment) to the final study visit

Conditions

  • Facial Rhytides
  • Skin Folds
  • Loss of Volume and Skin Quality

Interventions

  • JUVÉDERMDevice

    JUVÉDERM VOLBELLA with Lidocaine Treatment of any fine lines and medium-sized skin depressions. Can also be used for enhancement and pouting of the lips to correct structural defects such as asymmetry, contour deformities, volume loss. JUVÉDERM VOLIFT with Lidocaine Intended for the treatment of any deep skin depressions due to conditions such as premature aging. Can also be used for face contouring and volume restoration to correct facial structural defects such as asymmetry, contour deformities, volume loss in the lips, cheeks, chin, lower face. JUVÉDERM VOLUMA with Lidocaine Intended to restore volume of the face JUVÉDERM VOLITE with Lidocaine Intended for treatment, by filling, of superficial cutaneous depressions such as fine lines and for additional improvement of skin quality attributes such as hydration and elasticity. JUVÉDERM VOLUX with Lidocaine Intended to restore and generate facial volume in chin and mandible areas

  • BOTOXDrug

    Indicated for the treatment of hyperkinetic facial lines.

  • HArmonyCA LidocaineDevice

    HArmonyCa Lidocaine injectable gel is a dermal filler intended for facial soft tissue augmentation.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Change From Baseline in the Rasch-transformed Score of the FACE-Q Satisfaction With Facial Appearance Scale.Time frame: Visit 0 (Day 1) to Visit 7 (Up to approximately 5 months)

Locations

6 sites in 1 country. Site status is shown where the registry gives one.

  • Universidade de Sao Paulo - Sao Paulo /ID# 239163

    Rio de Janeiro, Brazil

  • Dermick Clinica de Dermatologia - Niteroi/Rio de Janeiro /ID# 239166

    São Paulo, Brazil

  • BRAVOMED Dermatology - Rio de Janeiro /ID# 239160

    São Paulo, Brazil

3 more study sites with a free account

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.